Skip to main content
. 2004 Apr;19(4):357–365. doi: 10.1111/j.1525-1497.2004.30613.x

Table 2.

Receipt of HCV Testing, Gastrointestinal Referral, Liver Biopsy, and HCV Treatment by HIV-positive Homeless and Marginally Housed Persons in San Francisco, 1997–2000, According to Selected Population Characteristics at Study Follow-up

HCV- tested Referred to GI Liver biopsied Offered therapy HCV- treated
HCV-positives 182 139 38 21 32 7
n (%) % (n/N) % (n/N) % (n/N) % (n/N) % (n/N)
Gender
 Male 145 (80) 75 (109) 21 (31) 12 (17) 19 (27) 5 (7)
 Female 37 (20) 81 (30) 19 (7) 11 (4) 14 (5) 0
Age
 <40 58 (32) 72 (42) 21 (12) 7 (4) 12 (7) 2 (1)
 40–46 60 (33) 80 (48) 23 (14) 10 (6) 18 (11) 5 (3)
 >46 64 (35) 77 (49) 19 (12) 17 (11) 22 (14) 5 (3)
Race/ethnicity
 White 78 (43) 90 (70) 31 (24)* 13 (10) 18 (14) 4 (3)
 African American 75 (41) 71 (53)* 16 (12) 11 (8) 17 (13) 4 (3)
 Latin 10 (6) 50 (5) 10 (1) 0 30 (3) 0
 Other 19 (10) 58 (11) 3 (1) 16 (3) 10 (2) 5 (1)
IDU history
 Yes 144 (79) 81 (117)* 23 (33) 12 (17) 16 (23) 3 (4)
 No 38 (21) 58 (22) 13 (5) 10 (4) 24 (9) 8 (3)
Current IDU (last 30 day)
 Yes 49 (27) 84 (41) 22 (11) 14 (7) 18 (9) 8 (4)
 No 133 (73) 74 (98) 20 (27) 10 (14) 17 (23) 2 (3)
Current HAART
 Yes 78 (43) 73 (57) 20 (16) 13 (10) 19 (15) 3 (2)
 No 104 (57) 79 (82) 21 (22) 11 (11) 16 (17) 5 (5)
ART adherence
 >90% 10 (13) 90 (19) 50 (5) 30 (3) 20 (2) 10 (1)
 70–90% 21 (27) 76 (17) 19 (4) 5 (1) 14 (3) 0
 <70% 34 (44) 68 (23) 15 (5) 18 (6) 21 (7) 0
In primary medical care§
 Yes 172 (94) 78 (134) 22 (38) 12 (21) 17 (30) 4 (7)
 No 10 (6) 50 (5) 0 0 20 (2) 0
In public health care system||
 Yes 133 (73) 80 (100) 18 (23) 11 (14) 14 (17) 3 (4)
 No 49 (27) 69 (34) 29 (14) 14 (7) 26 (13) 6 (3)
Homeless over 1 year
 Yes 112 (62) 72 (81) 20 (22) 9 (10) 16 (18) 3 (3)
 No 69 (38) 83 (57) 23 (16) 16 (11) 20 (14) 6 (4)
Alcohol use (days of last 30)
 none 114 (63) 75 (85) 20 (23) 11 (13) 18 (20) 4 (5)
 1–4 28 (15) 79 (22) 29 (8) 18 (5) 21 (6) 4 (1)
 >4 40 (22) 80 (32) 18 (7) 8 (3) 15 (6) 3 (1)
Depression (BDI score)#
 Minimal (<14) 75 (41) 72 (54) 21 (16) 12 (9) 12 (9) 1 (1)
 Mild-moderate (14–18) 63 (35) 76 (48) 21 (13) 8 (5) 21 (13) 6 (4)
 Severe (>28) 20 (11) 90 (18) 20 (4) 10 (2) 20 (4) 5 (1)
*

P < .05, compared within characteristic group for service analyzed. Characteristics determined within 28 days (median) of HCV data collection, unless otherwise noted.

Minimum of 3 drugs.

Based on available pill count from ART adherence substudy.

§

Contact with provider within the last 6 months.

||

The SFDPH Community Health Network.

Self-report at cohort baseline.

#

Reflect those participants undergoing Beck Depression Inventory (BDI) assessment within 102 days of HCV data collection.